Quick Answer
LB PHARMACEUTICALS INC reported Stockholders Equity of $301.31 million for the year ending 2025.
- LB PHARMACEUTICALS INC showed an increase of +418.7% in Stockholders Equity from 2024 to 2025.
- This data is from LB PHARMACEUTICALS INC's annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2024: -$50.45 million | Q2 2024: -$77.44 million | Q3 2024: -$91.45 million | Q1 2025: -$99.34 million | Q2 2025: -$103.87 million | Q3 2025: $310.22 million.
- Over the full 3 years of available data (2023 to 2025), LB PHARMACEUTICALS INC's Stockholders Equity has grown by 974.0%.
- Historical annual values: Fiscal year 2025: $301.31 million | Fiscal year 2024: -$94.55 million | Fiscal year 2023: -$34.47 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: